Search results
4 days ago · Johnson & Johnson. We’re building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal.
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange.Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000. Johnson & Johnson has a global workforce ...
Johnson & Johnson India recognized as a Kincentric Best Employer, 2020. Read the Story.
Johnson & Johnson Medical India is a leader in developing and systematically implementing an evidence-based approach toward the scientific basis of decision-making in healthcare. Learn More about our Approach. Our Commitment to Innovation. Innovation. September 23, 2020.
6 days ago · Johnson & Johnson reports Q2 2024 results • 2024 Second-Quarter reported sales growth of 4.3% to $22.4 Billion with operational growth of 6.6%* and adjusted operational growth of 6.5%*.Adjusted operational growth excluding COVID-19 Vaccine of 7.1%* • 2024 Second-Quarter Earnings per share (EPS) of $1.93 decreasing by 5.9% due to one-time special charges and adjusted EPS of $2.82 increasing by 10.2%* • Significant new product pipeline progress including TREMFYA IBD and subcutaneous ...
Every day, our more than 130,000 employees globally are building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal. At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress.
Johnson & Johnson Our Story explores the remarkable people, ideas, and products that have shaped Johnson & Johnson into one of the world’s most innovative healthcare companies.
4 days ago · London:Johnson & Johnson exceeded expectations in its second-quarter profit and revenue announced on Wednesday, propelled by robust sales of its drugs such as the cancer treatment Darzalex and the highly successful psoriasis drug Stelara. The company reported revenue of $22.4 billion, surpassing the consensus estimate of $22.3 billion based on data from LSEG. Adjusted earnings per share were $2.82, which exceeded analysts' expectations of $2.70 per share
4 days ago · The New Jersey-based drugmaker said it now expected total 2024 sales of $89.2 billion to $89.6 billion, compared with its prior forecast of $88.7 billion to $89.1 billion. J&J also lowered its ...
Nov 30, 2017 · 70 Years of Johnson & Johnson in India. Johnson & Johnson spread its root into India 70 years ago. Since then, the company has brought many innovative ideas, products and services to improve the health and well-being of people in India.
